Ignite Creation Date:
2024-05-05 @ 11:34 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00087386
Status:
TERMINATED
Last Update Posted:
2013-04-10
First Post:
2004-07-08
Brief Title:
Tanespimycin in Treating Patients With Stage III-IV Melanoma
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Stage IV Melanoma |
| Recurrent Melanoma |
| Stage III Melanoma |
Keywords: